Status: Recruiting
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam (S-649228) in Participants with Renal Impairment
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Qpex Biopharma, Inc.Updated: Nov 25, 2025Locations: 2
Eligibility criteria
Able to understand the study conduct and tasks required of the participants, sig... [+13]
Has unstable or new medical condition(s) [+20]